Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.
about
Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvementCorrelating pharmaceutical data with a national health survey as a proxy for estimating rural population health.Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort studyDeveloping a quality measure for clinical inertia in diabetes care.Understanding pharmacist decision making for adverse drug event (ADE) detection.Sustained hyperglycemia among patients with diabetes: what matters when action is needed?Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.Differences in the Use and Quality of Antidiabetic Therapies in Mexican American and Non-Hispanic Whites With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.A Comparison of the Use of Clinical-Guideline-Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012.Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications.
P2860
Q28195948-09D7516E-141E-494B-B03B-8B2A658ABE61Q33692442-F00C1817-04D8-442F-8719-985E907AF021Q33754547-FDA8260C-F712-4504-84C7-3D956B03E742Q34337783-C3693B62-D5DE-4914-893B-44B3D7801847Q35461828-FF38D361-85E9-4229-8CC7-4F9195B2D64BQ37269423-C0492AB0-5681-4D4C-A684-7403E8D0D628Q38086816-9028FD81-A0A8-4F64-87D4-97F0DD54CB7EQ38984724-2C737C18-AAEE-421F-ABFB-C40B3F1ADF24Q39398379-1F87776D-CA27-49DF-A6E3-A81991ACD4E6Q46520634-CDEA949D-9427-4518-9018-46CA409C50BCQ46627810-7B350233-4410-428F-AD55-D04D37969322
P2860
Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Linking pharmacy and laborator ...... are in patients with diabetes.
@ast
Linking pharmacy and laborator ...... are in patients with diabetes.
@en
type
label
Linking pharmacy and laborator ...... are in patients with diabetes.
@ast
Linking pharmacy and laborator ...... are in patients with diabetes.
@en
prefLabel
Linking pharmacy and laborator ...... are in patients with diabetes.
@ast
Linking pharmacy and laborator ...... are in patients with diabetes.
@en
P1433
P1476
Linking pharmacy and laborator ...... are in patients with diabetes.
@en
P2093
P304
P356
10.2337/DIACARE.23.11.1637
P407
P577
2000-11-01T00:00:00Z